Q2 FY2026 EarningsQ2 FY2026 results significantly beat consensus across the board: net revenue reached $28.5M vs. $12.7M expected, driven by a 190% QoQ surge in YARTEMLEA® sales. GAAP EPS of $0.15 and non-GAAP EPS of $0.02 both outperformed expectations of a loss (-$0.29 and -$0.33 respectively), marking a critical pivot to profitability. The company leveraged strong cash flow to aggressively de-risk its balance sheet, repurchasing 43% of its 2029 convertible notes.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Omeros(OMER) the Revenue is 28.53 M (--%), Beat estimate;the EBIT is 74 K (+100.2%), Beat estimate;the EPS is 0.15 (+134.9%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.03B--
0.01B--
+0.02B--%
EBITExceed expectations
0.00B100.23%
-0.02B33.86%
+0.02B66.37%
EPSExceed expectations
0.15134.88%
-0.293331.78%
+0.4433103.10%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf